Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Clinical trial NCT01518881 · TERMINATED

Trial details

NCT number: NCT01518881
Sponsor: Arbutus Biopharma Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Virus Infection

Start date: 2012-01-01
Primary completion: 2012-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.